Cargando…

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention

Detalles Bibliográficos
Autores principales:	Mortensen, Martin Bødtker, Falk, Erling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946870/ https://www.ncbi.nlm.nih.gov/pubmed/27941016 http://dx.doi.org/10.1093/eurheartj/ehw568

Ejemplares similares

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
por: Mortensen, Martin Bødtker, et al.
Publicado: (2017)

Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction
por: Mortensen, Martin Bødtker, et al.
Publicado: (2016)

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology
por: Kirchhof, Paulus, et al.
Publicado: (2014)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013)

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
por: Borén, Jan, et al.
Publicado: (2020)

Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction
por: Mortensen, Martin B, et al.
Publicado: (2014)

Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine
por: Parati, Gianfranco, et al.
Publicado: (2018)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017)

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?
por: Goldsmith, David, et al.
Publicado: (2018)

Global position paper on cardiovascular regenerative medicine
por: Fernández-Avilés, Francisco, et al.
Publicado: (2017)

Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
por: Fialkow, Jonathan
Publicado: (2016)

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
por: Sultana, Janet, et al.
Publicado: (2020)

UK Biobank: opportunities for cardiovascular research
por: Littlejohns, Thomas J, et al.
Publicado: (2019)

Muscle-strengthening Exercise Epidemiology: a New Frontier in Chronic Disease Prevention
por: Bennie, Jason A., et al.
Publicado: (2020)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Resources to Guide Exercise Specialists Managing Adults with Diabetes
por: Turner, Grant, et al.
Publicado: (2019)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
por: Nordestgaard, Børge G., et al.
Publicado: (2016)

Prevention and Treatment of Monkeypox
por: Rizk, John G., et al.
Publicado: (2022)

NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View
por: Angoulvant, Denis, et al.
Publicado: (2021)

Medical Information Delivering Improved Customer Experience: A Guide
por: Guillot, Pete, et al.
Publicado: (2023)

Lipoprotein(a) as a cardiovascular risk factor: current status
por: Nordestgaard, Børge G., et al.
Publicado: (2010)

Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
por: Napoli, Claudio, et al.
Publicado: (2020)

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
por: Mahfoud, Felix, et al.
Publicado: (2020)

The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016
por: Mathur, Anthony, et al.
Publicado: (2017)

The Critical Need to Build a European Governance Model for Online Access to Medical Information Services: A Position Paper
por: Pienaar, Stefne, et al.
Publicado: (2021)

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
por: Roberts, Melissa H., et al.
Publicado: (2020)

Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
por: Bello, Alfonso E., et al.
Publicado: (2014)

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022)

Measurement of Energy Intake Using the Principle of Energy Balance Overcomes a Critical Limitation in the Assessment of Energy Availability
por: Tarnowski, Caroline A., et al.
Publicado: (2023)

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
por: Mahfoud, Felix, et al.
Publicado: (2017)

Might Gendering Ski Binding Settings be Helpful for the Prevention of ACL Injuries Among Female Recreational Alpine Skiers?
por: Posch, Markus, et al.
Publicado: (2022)

Are the Current Guidelines on Caffeine Use in Sport Optimal for Everyone? Inter-individual Variation in Caffeine Ergogenicity, and a Move Towards Personalised Sports Nutrition
por: Pickering, Craig, et al.
Publicado: (2017)

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology
por: Maack, Christoph, et al.
Publicado: (2018)

Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide
por: Kow, Chia Siang, et al.
Publicado: (2020)

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
por: Scigliano, Giulio, et al.
Publicado: (2013)

‘Knowing as we go’: a Hunter-Gatherer Behavioural Model to Guide Innovation in Sport Science
por: Woods, Carl T., et al.
Publicado: (2020)

Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
por: Koufakis, Theocharis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dlna618c32utg09hs8vql70en